Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Description | Evotaz 300mg/150mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 30 tablet |
| BNF code | 0503010ALBBAAAA |
| Virtual Medicinal Product Pack | Atazanavir 300mg / Cobicistat 150mg tablets 30 tablet |
| Actual Medicinal Product | Evotaz 300mg/150mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) |
| Legal category | POM |
| Product Prescribing Information | |
|---|---|
| Schedule 2 | ✗ |
| ACBS | ✗ |
| Personally administered | ✗ |
| FP10 MDA Prescription | ✗ |
| Schedule 1 | ✗ |
| Hospital | ✓ |
| Nurse formulary | ✗ |
| Nurse extended formulary | ✗ |
| Dental formulary | ✗ |
| Medicinal Product Price | |
| Price (pence) | 32338 |
| Price basis | NHS Indicative Price |
| Reimbursement Information | |
| Prescription charges | 1 |
| Dispensing fees | 1 |
| Broken bulk | ✓ |
| Calendar pack | ✗ |
| FP34D prescription item | ✗ |
| Global Trade Item Number | |
| GTIN | 5012712043492 |
| GTIN date | 19 Nov 2018 |
| The date the GTIN became invalid | 12 Jan 2023 |
| Global Trade Item Number | |
| GTIN | 5012712043492 |
| GTIN date | 13 Jan 2023 |
dm+d data retrieved from TRUD: release NHSBSA_4.3.0_20240422000001, imported on 22nd April 2024 at 05:06:50.